Literature DB >> 31655362

Raman and FTIR spectroscopy in determining the chemical changes in healthy brain tissues and glioblastoma tumor tissues.

J Depciuch1, B Tołpa2, P Witek3, K Szmuc3, E Kaznowska4, M Osuchowski4, P Król5, J Cebulski3.   

Abstract

Glioblastoma, also called glioblastoma multiforme (GBM), is a particularly malignant form of primary brain tumor. This cancer accounts for 12-15% of all brain tumors. Despite the advances in neurosurgery, radio and chemotherapy the average survival rate is only 12.1-16.6 months. This is due not only to the late diagnosis of the disease, but also to ineffective treatment methods which result from the still low knowledge about the causes of glioblastoma development. Therefore, it is very important to look for new diagnostic methods of detection of the smallest features of cancer. Raman and infrared spectroscopy (FTIR) can be such methods. In this paper we discuss the chemical composition of sample glioblastoma brain tissues and marginal brain tissues using these two spectroscopy methods. Raman and FTIR spectra of cancer brain tissues showed that the highest differences in the chemical composition, compared to the control brain tissue, occur in the areas corresponding to lipids, collagen and proteins. Moreover, Raman spectroscopy also showed significant changes in the cancer tissues in the phosphatidylcholine and sphingomyelin. Interestingly, FTIR spectra after Kramers-Kronig transformations showed signals only for three peaks which corresponded to the vibrations of lipid function groups. Adjustment of the Lorenz function for these three peaks showed that only in the case of cancerous tissues the number of matching lines is different, compared to the control and marginal tissues. Therefore, we assume that lipids could be a spectroscopic marker for brain tumor. Furthermore, principal component analysis (PCA) showed that chemical changes seen between cancer and control tissues are significant and it is possible to differentiate the infected tissue from the healthy one. Interestingly, the PCA analysis also showed that adjacent brain tissues have different chemical composition than the control tissues.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FTIR; Glioblastoma; Kramers-Kronig; Raman spectroscopy; Spectroscopic marker

Mesh:

Substances:

Year:  2019        PMID: 31655362     DOI: 10.1016/j.saa.2019.117526

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  7 in total

1.  The Spectroscopic Similarity between Breast Cancer Tissues and Lymph Nodes Obtained from Patients with and without Recurrence: A Preliminary Study.

Authors:  Joanna Depciuch; Agata Stanek-Widera; Nadia Khinevich; Hanna V Bandarenka; Michal Kandler; Vadim Bayev; Julia Fedotova; Dariusz Lange; Jadwiga Stanek-Tarkowska; Jozef Cebulski
Journal:  Molecules       Date:  2020-07-21       Impact factor: 4.411

2.  Integration of Raman spectra with transcriptome data in glioblastoma multiforme defines tumour subtypes and predicts patient outcome.

Authors:  Pierre-Jean Le Reste; Eleftherios Pilalis; Marc Aubry; Mari McMahon; Luis Cano; Amandine Etcheverry; Aristotelis Chatziioannou; Eric Chevet; Alain Fautrel
Journal:  J Cell Mol Med       Date:  2021-11-12       Impact factor: 5.310

Review 3.  Raman Spectroscopy as a Neuromonitoring Tool in Traumatic Brain Injury: A Systematic Review and Clinical Perspectives.

Authors:  Andrew R Stevens; Clarissa A Stickland; Georgia Harris; Zubair Ahmed; Pola Goldberg Oppenheimer; Antonio Belli; David J Davies
Journal:  Cells       Date:  2022-04-05       Impact factor: 6.600

4.  Simultaneous FTIR and Raman Spectroscopy in Endometrial Atypical Hyperplasia and Cancer.

Authors:  Edyta Barnas; Joanna Skret-Magierlo; Andrzej Skret; Ewa Kaznowska; Joanna Depciuch; Kamil Szmuc; Kornelia Łach; Izabela Krawczyk-Marć; Jozef Cebulski
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

5.  Altered Elemental Distribution in Male Rat Brain Tissue as a Predictor of Glioblastoma Multiforme Growth-Studies Using SR-XRF Microscopy.

Authors:  Karolina Planeta; Zuzanna Setkowicz; Mateusz Czyzycki; Natalia Janik-Olchawa; Damian Ryszawy; Krzysztof Janeczko; Rolf Simon; Tilo Baumbach; Joanna Chwiej
Journal:  Int J Mol Sci       Date:  2022-01-09       Impact factor: 6.208

Review 6.  DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.

Authors:  Ola Rominiyi; Spencer J Collis
Journal:  Mol Oncol       Date:  2021-06-11       Impact factor: 6.603

7.  Development of a Nomogram Based on Preoperative Bi-Parametric MRI and Blood Indices for the Differentiation Between Cystic-Solid Pituitary Adenoma and Craniopharyngioma.

Authors:  Zhen Zhao; Dongdong Xiao; Chuansheng Nie; Hao Zhang; Xiaobing Jiang; Ali Rajab Jecha; Pengfei Yan; Hongyang Zhao
Journal:  Front Oncol       Date:  2021-07-09       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.